The Auxiliary Effect of Artificial Intelligence in the Detection of Precancerous Lesions in Proximal Colon Cancer
Starting soon
Conditions studied: Abdominal Pain, Black Stools, Constipation, Diarrhea
In brief
The investigators conducted a multicenter randomized controlled trial to explore the adjuvant effect of artificial intelligence in the detection of precancerous lesions in the proximal colon.This is a prospective, multicenter, single-blind, parallel randomized controlled trial.During the colonoscopy retraction process, the investigators aimed to compare the detection rates of proximal colon adenomas with and without the assistance of an AI(Artificial Intelligence) diagnostic device.
Key facts
- Study ID
- NCT07338643
- Run by
- Limian Er
- People needed
- 1200
- Starts
- 2026-02-26
- Expected to finish
- 2028-08-01
- Last updated by the study team
- 2026-01-14
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with symptoms such as abdominal pain, black stools, constipation, or diarrhea undergo colonoscopy for diagnostic purposes.
You may not qualify if…
- Those with inflammatory bowel disease, colorectal cancer and surgical history, as well as those with familial polyposis syndrome
- Those with intestinal obstruction or malignant tumors
- Patients with colorectal lesions that need to be treated in stages.
- Other contraindications for colonoscopy examination.
Where it is running
- the Fourth Hospital of Hebei Medical University — Shijiazhuang, Hebei, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.